↓ Skip to main content
Dove Medical Press
Article Metrics
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
Current status of poly(ADP-ribose) polymerase inhibitors and future directions
Overview of attention for article published in OncoTargets and therapy, October 2017
Altmetric Badge
About this Attention Score
Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)
Mentioned by
twitter
4
X users
patent
5
patents
facebook
1
Facebook page
Citations
dimensions_citation
104
Dimensions
Readers on
mendeley
138
Mendeley
citeulike
1
CiteULike
Summary
X
Patents
Facebook
Dimensions citations
So far, Altmetric has seen
5
patents that reference this research output.
Quinazolinones as PARP14 inhibitors
Grant US-11958837-B2
United States of America
16 Apr 2024
Niraparib formulations
Grant US-11730725-B2
United States of America
22 Aug 2023
Niraparib compositions
Grant US-11673877-B2
United States of America
13 Jun 2023
Quinazolinones as PARP14 inhibitors
Grant US-11008308-B2
United States of America
18 May 2021
Quinazolinones as PARP14 inhibitors
Grant US-10562891-B2
United States of America
18 Feb 2020